Dr. Gordon B. Mills on Moving Toward Patient-Specific Treatment in Breast Cancer

Gordon B. Mills, MD, PhD

​Gordon B. Mills, MD, PhD, says individualized treatment, as opposed to treating patients solely based on their malignancy type, must happen in order to improve patient outcome.

Gordon B. Mills, MD, PhD, chair of Systems Biology, co-director of the Institute of Personalized Medicine, University of Texas MD Anderson Cancer Center, discusses the oncological trend of moving toward individually treating patients with breast cancer. Mills says this individualized treatment, as opposed to treating patients solely based on their malignancy type, must happen in order to improve patient outcome.